Sex differences and gonadal hormone influences in drug addiction and sexual behavior: progress and possibilities.
Wetherington
Cora Lee
CL
National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 4282 MSC 9555, Bethesda, Maryland 20892-9555, USA. cwetheri@nida.nih.gov
D045930:Anabolic Agents / Q000008:administration & dosage / Q000494:pharmacology; D000701:Analgesics, Opioid / Q000493:pharmacokinetics / Q000494:pharmacology; D000818:Animals; D005260:Female; D042341:Gonadal Hormones / Q000378:metabolism*; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy / Q000503:physiopathology; D012727:Sex Characteristics; D012737:Sex Factors; D012725:Sexual Behavior / Q000502:physiology*; D012726:Sexual Behavior, Animal / Q000502:physiology*; D013256:Steroids / Q000008:administration & dosage / Q000494:pharmacology; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000503:physiopathology*
D045930:Anabolic Agents; D000701:Analgesics, Opioid; D042341:Gonadal Hormones; D013256:Steroids